Orizuru Therapeutics promotes the social implementation of cell therapy products and innovative iPS cell-related technologies (platform innovation).

Company Overview

Scope of
Business

1. Development of regenerative medical products through cell transplantation.
2. Support for drug discovery research and development of regenerative medicine research infrastructure by utilizing iPS cell-related technologies.

Company Name

Orizuru Therapeutics, Inc.

Founded

April 9, 2021

Address

2-26-1 Muraoka-higashi, Fujisawa-shi, Kanagawa, 251-8555 Japan

Representative
Director

Kenji Nonaka

Company
Information

Japanese (Download)　/　English (Download)

Shareholders

Kyoto University Innovation Capital Co., Ltd.
Takeda Pharmaceutical Company Limited
SMBC Venture Capital Co., Ltd.
MUFG Bank, Ltd.
MEDIPAL HOLDINGS CORPORATION
Sumitomo Mitsui Finance and Leasing Company Co. Ltd.
Sumitomo Mitsui Trust Bank, Limited
Nippon Venture Capital Co., Ltd.
Japan Growth Capital Investment Corporation
JDRF T1D Fund, LLC.

Access

Locations

Shonan Health Innovation park, 2-26-1 Muraoka-higashi, Fujisawa-shi, Kanagawa, 251-8555 Japan

By train

From JR Ofuna Station
Take the Enoden Bus toward Fujisawa Station Kitaguchi (bus stop No. 1 at the East Exit bus terminal south of Lumine Wing)
and get off at Shonan iPark. (Approx. 15 mins)

From JR Fujisawa Station
Take the Enoden Bus toward Ofuna Station Higashiguchi Shiki-no Mori (bus stop No. 9 at the North Exit bus terminal)
and get off at Shonan iPark. (Approx. 15 mins)

By car

From Tokyo
About 11 km from the Kamiyabe Interchange on the Yokohama Bypass (Yokohama Shindo) via Route 1 Harajuku

From Odawara
About 6 km from the Fujisawa Interchange on the Shin-Shonan Bypass via Fujisawa-Bashi